AwardedSpainGoods
Suministro del principio activo denominado UPADACITINIB 45 MG COMPRIMIDOS LIBERACIÓN PROLONGADA (RINVOQ ®) para el Servicio de Farmacia del Complejo Hospitalario Universitario de Canarias
- Published
- Published 25 February 2025
Overview
Suministro del principio activo denominado UPADACITINIB 45 MG COMPRIMIDOS LIBERACIÓN PROLONGADA (RINVOQ ®) para el Servicio de Farmacia del Complejo Hospitalario Universitario de Canarias
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 25 February 2025
Various medicinal products
Award outcome
- Awarded value
- €107,583
- Award date
- 27 January 2025
- ABBVIE SPAIN, S.L.U.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
25 February 2025
Contracting authority
Dirección Gerencia del Complejo Hospitalario Universitario de Canarias
Procuring entitySanta Cruz de Tenerife, Spain
ID_PLATAFORMA: 21063730150133
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.